Henry McSorley

Dr. Henry McSorley


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in Immunity
Verified
Journal Article
Open access
RMRick M. Maizels
Rick M. Maizels
HSHermelijn H. Smits
Hermelijn H. Smits
HMHenry McSorley
Henry McSorley
Helminths are extraordinarily successful parasites due to their ability to modulate the host immune response. They have evolved a spectrum of immunomodulatory molecules that are now beginning to be defined, heralding a molecular revolution in parasite immunology. These discoveries have the potential both to transform our understanding of parasite adaptation to the host and to develop possible therapies for immune-mediated disease. In this review we will summarize the current state of the art in parasite immunomodulation and discuss perspectives on future areas for research and discovery.

1 October 2017 in Immunity
Verified
Journal Article
Open access
MOMegan Osbourn
Megan Osbourn
DSDinesh C. Soares
Dinesh C. Soares
FVFrancesco Vacca
Francesco Vacca
ECE. Suzanne Cohen
E. Suzanne Cohen
ISIan C. Scott
Ian C. Scott
HMHenry McSorley
Henry McSorley
Infection by helminth parasites is associated with amelioration of allergic reactivity, but mechanistic insights into this association are lacking. Products secreted by the mouse parasite Heligmosomoides polygyrus suppress type 2 (allergic) immune responses through interference in the interleukin-33 (IL-33) pathway. Here, we identified H. polygyrus Alarmin Release Inhibitor (HpARI), an IL-33-suppressive 26-kDa protein, containing three predicted complement control protein (CCP) modules. In vivo, recombinant HpARI abrogated IL-33, group 2 innate lymphoid cell (ILC2) and eosinophilic responses to Alternaria allergen administration, and diminished eosinophilic responses to Nippostrongylus brasiliensis, increasing parasite burden. HpARI bound directly to both mouse and human IL-33 (in the cytokine's activated state) and also to nuclear DNA via its N-terminal CCP module pair (CCP1/2), tethering active IL-33 within necrotic cells, preventing its release, and forestalling initiation of type 2 allergic responses. Thus, HpARI employs a novel molecular strategy to suppress type 2 immunity in both infection and allergy.

18 May 2020 in eLife
Verified
Journal Article
Open access
FVFrancesco Vacca
Francesco Vacca
CCCaroline Chauché
Caroline Chauché
AJAbhishek Jamwal
Abhishek Jamwal
EHElizabeth C Hinchy
Elizabeth C Hinchy
GHGraham Heieis
Graham Heieis
HMHenry McSorley
Henry McSorley
The IL-33-ST2 pathway is an important initiator of type 2 immune responses. We previously characterised the HpARI protein secreted by the model intestinal nematode Heligmosomoides polygyrus, which binds and blocks IL-33. Here, we identify H. polygyrus Binds Alarmin Receptor and Inhibits (HpBARI) and HpBARI_Hom2, both of which consist of complement control protein (CCP) domains, similarly to the immunomodulatory HpARI and Hp-TGM proteins. HpBARI binds murine ST2, inhibiting cell surface detection of ST2, preventing IL-33-ST2 interactions, and inhibiting IL-33 responses in vitro and in an in vivo mouse model of asthma. In H. polygyrus infection, ST2 detection is abrogated in the peritoneal cavity and lung, consistent with systemic effects of HpBARI. HpBARI_Hom2 also binds human ST2 with high affinity, and effectively blocks human PBMC responses to IL-33. Thus, we show that H. polygyrus blocks the IL-33 pathway via both HpARI which blocks the cytokine, and also HpBARI which blocks the receptor.

22 December 2020 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
JMJana Meiners
Jana Meiners
MRMartina Reitz
Martina Reitz
NRNikolas Rüdiger
Nikolas Rüdiger
JTJan-Eric Turner
Jan-Eric Turner
LHLennart Heepmann
Lennart Heepmann
MBminka breloer
minka breloer
Parasitic helminths are sensed by the immune system via tissue-derived alarmins that promote the initiation of the appropriate type 2 immune responses. Here we establish the nuclear alarmin cytokine IL-33 as a non-redundant trigger of specifically IL-9-driven and mast cell-mediated immunity to the intestinal parasiteStrongyloides ratti. Blockade of endogenous IL-33 using a helminth-derived IL-33 inhibitor elevated intestinal parasite burdens in the context of reduced mast cell activation while stabilization of endogenous IL-33 or application of recombinant IL-33 reciprocally reduced intestinal parasite burdens and increased mast cell activation. Using gene-deficient mice, we show that application of IL-33 triggered rapid mast cell-mediated expulsion of parasites directly in the intestine, independent of the adaptive immune system, basophils, eosinophils or Gr-1+cells but dependent on functional IL-9 receptor and innate lymphoid cells (ILC). Thereby we connect the described axis of IL-33-mediated ILC2 expansion to the rapid initiation of IL-9-mediated and mast cell-driven intestinal anti-helminth immunity.

1 March 2021 in Seminars in Immunology
Verified
Journal Article
Closed access
HMHenry McSorley
Henry McSorley
DSDanielle J. Smyth
Danielle J. Smyth

7 February 2019 in Pediatric Allergy and Immunology
Verified
Journal Article
Closed access
PDF file
KJKristina Johansson
Kristina Johansson
HMHenry McSorley
Henry McSorley